secwatch / observer

8-K filed May 28, 2026, 4:07 PM ET ticker PEB CIK 0001474098

other material confidence high sentiment positive materiality 0.70

Pebblebrook sells The Chamberlain West Hollywood for $43.5M; updates 2026 outlook

Pebblebrook Hotel Trust

Sold 115-room Chamberlain West Hollywood Hotel for $43.5M (14.5x EBITDA, 5.9% cap rate) on May 27, 2026.
Accepted $33.7M liquidation preference of preferred shares as partial consideration, retiring them at a 23% discount ($26.1M value).
Since late 2025: reduced debt by ~$160M, retired $47M preferred at avg 23% discount, repurchased $62M common (5.4M shares at $11.51 avg).
Full-year 2026 Adjusted EBITDA re lowered $1.5M to $334.5-$346.5M; AFFO per share unchanged at $1.60-$1.70.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001474098-26-000042
form_type: 8-K
ticker: PEB
cik: 0001474098
company_name: Pebblebrook Hotel Trust
filed_at: 2026-05-28T20:07:43+00:00
discovered_at: 2026-05-28T20:09:00.350284+00:00
generated_at: 2026-05-28T20:55:59.098731+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001474098-26-000042
json_url: https://secwatch.observer/filing/0001474098-26-000042.json
markdown_url: https://secwatch.observer/filing/0001474098-26-000042.md
text_url: https://secwatch.observer/filing/0001474098-26-000042.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1474098/000147409826000042/0001474098-26-000042-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1474098/000147409826000042/peb-20260527.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NXTC

NextCure Phase 1 SIM0505 data: 55% ORR in gynecologic cancers; cash into Q1 2027

NextCure, Inc. June 1, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JBIO

Jade Biosciences reports Phase 1 interim data: JADE101 shows ~70% IgA reduction, favorable safety, differentiated PK

Jade Biosciences, Inc. June 1, 2026, 7:55 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EIKN

Eikon reports 63.1% ORR in Phase 2 NSCLC trial of EIK1001; PARP1 inhibitor EIK1003 shows 24.5% ORR with paclitaxel

Eikon Therapeutics, Inc. June 1, 2026, 7:30 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

GIPR

Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit

GENERATION INCOME PROPERTIES, INC. June 1, 2026, 5:27 PM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001474098-26-000042

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.